Loading...
p27 Kip 1 Rabbit mAb

57386

p27 Kip 1 Rabbit mAb

p27 Kip 1 Rabbit mAb (catalogue number 57386) is a rabbit-derived primary antibody validated for WB IHC IP, reactive with Human, Mouse samples. It targets Cyclin-dependent kinase inhibitor 1B (Cdkn1b): Important regulator of cell cycle progression. Supplied as 100ul at ₪1,627.49; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human, Mouse
Applications
WB IHC IP
UniProt ID
P46414
Gene
Cdkn1b
Target organism
Mus musculus
Catalogue number
57386
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Cyclin-dependent kinase inhibitor 1B (Cdkn1b) · Mus musculus

Important regulator of cell cycle progression. Inhibits the kinase activity of CDK2 bound to cyclin A, but has little inhibitory activity on CDK2 bound to SPDYA. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1-CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichiometry

Subcellular location: Nucleus; Cytoplasm; Endosome

Sequence length: 197 aa · 22193 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.